Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prokaryotics Inc.

http://prokaryotics.com

Latest From Prokaryotics Inc.

Tech Transfer Roundup: OncoSec Will Investigate CAR-T In Breast Cancer With Dana-Farber

Building on research by Dana-Farber professor Wayne Marasco, the partners are backing a bispecific approach to CAR-Ts in solid tumors. Seelos licenses a Parkinson’s gene therapy candidate from Duke.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Prokaryotics Inc.
  • Senior Management
  • Keith Bostian, Acting CEO
    Steve Lesiak, Acting CFO
    Terry Roemer, CSO
    Pamela Demain, VP, Bus. Dev.
  • Contact Info
  • Prokaryotics Inc.
    Phone: (908) 737-1922
    1000 Morris Ave., STEM Bldg. Suite 5-13
    Union, NJ 07083
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register